Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKinsey
Harvard Business School
Argus Health
Johnson and Johnson
QuintilesIMS
Boehringer Ingelheim
AstraZeneca
Dow

Generated: January 23, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: lisdexamfetamine dimesylate

« Back to Dashboard

lisdexamfetamine dimesylate Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Mylan Pharms Inc lisdexamfetamine dimesylate 202835 50MG CAPSULE;ORAL
Actavis Elizabeth lisdexamfetamine dimesylate 202802 50MG CAPSULE;ORAL
Sandoz Inc lisdexamfetamine dimesylate 202836 40MG CAPSULE;ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Baxter
McKinsey
Chinese Patent Office
Deloitte
UBS
Federal Trade Commission
QuintilesIMS
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.